Cargando…

Requirements and Pitfalls of Dialyzer Sieving Coefficients Comparisons

Sieving coefficients reported in dialyzer data sheets and instructions for use (IFUs) indicate the potential of different solutes to pass across a particular membrane. Despite being measured in vitro, sieving coefficient data are often used as a predictor of the clinical performance of dialyzers. Al...

Descripción completa

Detalles Bibliográficos
Autores principales: Hulko, Michael, Haug, Ulrike, Gauss, Julia, Boschetti‐de‐Fierro, Adriana, Beck, Werner, Krause, Bernd
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6585607/
https://www.ncbi.nlm.nih.gov/pubmed/30281162
http://dx.doi.org/10.1111/aor.13278
_version_ 1783428732684337152
author Hulko, Michael
Haug, Ulrike
Gauss, Julia
Boschetti‐de‐Fierro, Adriana
Beck, Werner
Krause, Bernd
author_facet Hulko, Michael
Haug, Ulrike
Gauss, Julia
Boschetti‐de‐Fierro, Adriana
Beck, Werner
Krause, Bernd
author_sort Hulko, Michael
collection PubMed
description Sieving coefficients reported in dialyzer data sheets and instructions for use (IFUs) indicate the potential of different solutes to pass across a particular membrane. Despite being measured in vitro, sieving coefficient data are often used as a predictor of the clinical performance of dialyzers. Although standards for the measurement of sieving coefficients exist, the stated methodologies do not offer sufficient guidance to ensure comparability of test results between different dialyzers. The aim of this work was to investigate the relationship between sieving coefficients and published clinical performance indicators for two solutes, albumin loss and beta‐2 microglobulin (β(2)M) reduction ratio (RR), and to assess the impact of different in vitro test parameters on sieving coefficient values for albumin, β(2)M, and myoglobin. Clinical albumin loss and β(2)M RR for commercially available dialyzers used in hemodialysis (HD) and post‐dilution hemodiafiltration (HDF) were extracted from the literature and plotted against sieving coefficients reported in data sheets and IFUs. Albumin, β(2)M, and myoglobin sieving coefficients of a selection of dialyzers were measured per the ISO 8637 standard. The impact of in vitro testing conditions was assessed by changing blood flow rate, ultrafiltration (UF) rate, sampling time, and origin of test plasma. Results showed variation in albumin loss and β(2)M RR for the same sieving coefficient across different dialyzers in HD and HDF. Changes in blood flow rates, UF rates, sampling time, and test plasma (bovine vs. human) caused marked differences in sieving coefficient values for all investigated solutes. When identical testing conditions were used, sieving coefficient values for the same dialyzer were reproducible. Testing conditions have a marked impact on the measurement of sieving coefficients, and values should not be compared unless identical conditions are used. Further, variability in observed clinical data in part reflects the lack of definition of test conditions.
format Online
Article
Text
id pubmed-6585607
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-65856072019-06-27 Requirements and Pitfalls of Dialyzer Sieving Coefficients Comparisons Hulko, Michael Haug, Ulrike Gauss, Julia Boschetti‐de‐Fierro, Adriana Beck, Werner Krause, Bernd Artif Organs Main Text Articles Sieving coefficients reported in dialyzer data sheets and instructions for use (IFUs) indicate the potential of different solutes to pass across a particular membrane. Despite being measured in vitro, sieving coefficient data are often used as a predictor of the clinical performance of dialyzers. Although standards for the measurement of sieving coefficients exist, the stated methodologies do not offer sufficient guidance to ensure comparability of test results between different dialyzers. The aim of this work was to investigate the relationship between sieving coefficients and published clinical performance indicators for two solutes, albumin loss and beta‐2 microglobulin (β(2)M) reduction ratio (RR), and to assess the impact of different in vitro test parameters on sieving coefficient values for albumin, β(2)M, and myoglobin. Clinical albumin loss and β(2)M RR for commercially available dialyzers used in hemodialysis (HD) and post‐dilution hemodiafiltration (HDF) were extracted from the literature and plotted against sieving coefficients reported in data sheets and IFUs. Albumin, β(2)M, and myoglobin sieving coefficients of a selection of dialyzers were measured per the ISO 8637 standard. The impact of in vitro testing conditions was assessed by changing blood flow rate, ultrafiltration (UF) rate, sampling time, and origin of test plasma. Results showed variation in albumin loss and β(2)M RR for the same sieving coefficient across different dialyzers in HD and HDF. Changes in blood flow rates, UF rates, sampling time, and test plasma (bovine vs. human) caused marked differences in sieving coefficient values for all investigated solutes. When identical testing conditions were used, sieving coefficient values for the same dialyzer were reproducible. Testing conditions have a marked impact on the measurement of sieving coefficients, and values should not be compared unless identical conditions are used. Further, variability in observed clinical data in part reflects the lack of definition of test conditions. John Wiley and Sons Inc. 2018-10-03 2018-12 /pmc/articles/PMC6585607/ /pubmed/30281162 http://dx.doi.org/10.1111/aor.13278 Text en © Baxter International Inc. Artificial Organs published by Wiley Periodicals, Inc. on behalf of International Center for Artificial Organ and Transplantation (ICAOT) This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Main Text Articles
Hulko, Michael
Haug, Ulrike
Gauss, Julia
Boschetti‐de‐Fierro, Adriana
Beck, Werner
Krause, Bernd
Requirements and Pitfalls of Dialyzer Sieving Coefficients Comparisons
title Requirements and Pitfalls of Dialyzer Sieving Coefficients Comparisons
title_full Requirements and Pitfalls of Dialyzer Sieving Coefficients Comparisons
title_fullStr Requirements and Pitfalls of Dialyzer Sieving Coefficients Comparisons
title_full_unstemmed Requirements and Pitfalls of Dialyzer Sieving Coefficients Comparisons
title_short Requirements and Pitfalls of Dialyzer Sieving Coefficients Comparisons
title_sort requirements and pitfalls of dialyzer sieving coefficients comparisons
topic Main Text Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6585607/
https://www.ncbi.nlm.nih.gov/pubmed/30281162
http://dx.doi.org/10.1111/aor.13278
work_keys_str_mv AT hulkomichael requirementsandpitfallsofdialyzersievingcoefficientscomparisons
AT haugulrike requirementsandpitfallsofdialyzersievingcoefficientscomparisons
AT gaussjulia requirementsandpitfallsofdialyzersievingcoefficientscomparisons
AT boschettidefierroadriana requirementsandpitfallsofdialyzersievingcoefficientscomparisons
AT beckwerner requirementsandpitfallsofdialyzersievingcoefficientscomparisons
AT krausebernd requirementsandpitfallsofdialyzersievingcoefficientscomparisons